NKGen Biotech Korea Co ltd (182400) Stock Price & News

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2.21B	2.21B	1.57B	2.14B
Cost of goods sold	391.88M	578.36M	241.90M	410.63M
Cost of revenue	391.88M	578.36M	241.90M	410.63M
Research and development expenses	642.10M	454.60M	472.72M	358.00M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.23B	2.29B	1.33B	1.19B
Operating expense	1.86B	4.57B	2.22B	1.86B
Total operating expenses	2.25B	5.15B	2.46B	2.27B
Operating income	-48.73M	-2.93B	-890.12M	-129.89M
Other non operating income	355.34M	-619.47M	-145.46K	3.31M
EBT including unusual items	215.79M	-782.85M	-592.63M	-176.78M
EBT excluding unusual items	509.09M	-3.68B	-626.82M	-142.96M
Income tax expense	-	-	-27.79M	13.90M
Effective tax rate	-	-	4.69%	-7.86%
Other operating expenses	43.89M	41.92M	58.49M	40.23M
Net income	215.79M	-782.85M	-564.84M	-190.68M
Net profit margin	9.78%	-35.41%	-35.87%	-8.92%
Earnings per share	-	-	-	-
Interest and investment income	162.88M	-	27.58M	16.91M
Interest expense	-19.64M	-84.93M	-120.33M	-119.12M
Net interest expenses	143.24M	-84.93M	-92.75M	-102.21M
Depreciation and amortization charges	42.78M	79.26M	200.33M	251.59M
EBITDA	8.66M	-2.84B	-675.04M	136.48M
Gain or loss from assets sale	-106.27M	106.27M	-	-369.97M

Finance